Search

Your search keyword '"Dols-Icardo, Oriol"' showing total 380 results

Search Constraints

Start Over You searched for: Author "Dols-Icardo, Oriol" Remove constraint Author: "Dols-Icardo, Oriol"
380 results on '"Dols-Icardo, Oriol"'

Search Results

1. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

2. X‐chromosome-wide association study for Alzheimer’s disease

3. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

6. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

7. Cortical microstructure in primary progressive aphasia: a multicenter study

8. Correction: Cortical microstructure in primary progressive aphasia: a multicenter study

9. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

10. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

11. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

12. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

13. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

14. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

15. Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis.

16. Smoking is associated with age at disease onset in Parkinson's disease

17. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration

18. Identification of a pathogenic mutation in ARPP21in patients with amyotrophic lateral sclerosis

19. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

21. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

22. Clinicopathological correlates in frontotemporal lobar degeneration: motor neuron disease spectrum

23. The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease.

24. Clinicopathological correlates in the frontotemporal lobar degeneration–motor neuron disease spectrum.

25. The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

26. C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

27. Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia

28. Global analysis of synapse‐enriched miRNA in Alzheimer’s disease temporal cortex post‐mortem

29. LC‐MS/MS‐based proteome profiling of CSF‐derived extracellular vesicles in Alzheimer’s disease

30. Biofluid markers of Alzheimer’s disease‐associated CNS inflammation in adults with Down syndrome

31. Transferability of a European-derived Alzheimer’s Disease Genetic Risk Score across Multi-Ancestry Populations

32. Cortical microstructure in the amyotrophic lateral sclerosis–frontotemporal dementia continuum

33. Brain hypometabolism in non‐demented microtubule‐associated protein tau H1 carriers with Parkinson's disease

34. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

36. APOE4homozygosity represents a distinct genetic form of Alzheimer’s disease

37. Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia

38. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies

39. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease

40. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies

41. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease

42. Amyloid Precursor Protein 𝛽CTF accumulates in synapses in sporadic and genetic forms of Alzheimer's disease

43. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis

45. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum

46. Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis

47. Transcriptome wide correlations with neuropathological hallmarks in the frontal cortex of FTLD patients

49. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation

50. Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes

Catalog

Books, media, physical & digital resources